basal cell carcinoma

JDD December Editor’s Picks: A Spotlight on Dermatology’s Latest Innovations
acneAs 2024 comes to a close, the Journal of Drugs in Dermatology delivers a stellar lineup of research, reviews, and insights to inform your practice and inspire your curiosity. This month's Editor's Picks feature cutting-edge studies and expert commentary on a range of topics, from advanced acne treatments to groundbreaking leadership initiatives in dermatology. Laser and Energy Treatments for Ac …
acne
Cemiplimab Therapeutic Cheat Sheet
CemiplimabCemiplimab is a monoclonal antibody therapy that has emerged as a promising treatment option for certain types of advanced skin cancer. Specifically designed to target the programmed cell death protein 1 (PD-1) pathway, cemiplimab works by blocking the interaction between PD-1 and its ligands, PD-L1 and PD-L2, thereby unleashing the body's immune system to recognize and attack cancer cells. We con …
Cemiplimab
Basal Cell Carcinoma – Friday Pop Quiz 12/22/2023
A 91-year-old man with a history of basal cell carcinoma presents for evaluation of the shown lesions on his scalp. His daughter, a nurse who is present with him for his appointment, notes that he had purulent bumps in the same area a few days earlier. Which of the following is the most appropriate treatment for the patient’s condition? A. Oral cefdinir B. Patch testing C. Skin biop …